247 related articles for article (PubMed ID: 16998334)
1. Treatment of facial angiofibroma of tuberous sclerosis using cultured epithelial autografts.
Hori K; Soejima K; Nozaki M; Sakurai H; Takeuchi M; Yamaki T; Iwasaka S; Kono T; Honda T; Isago T
Ann Plast Surg; 2006 Oct; 57(4):415-7. PubMed ID: 16998334
[TBL] [Abstract][Full Text] [Related]
2. New technique using combined pulsed dye laser and fractional resurfacing for treating facial angiofibromas in tuberous sclerosis.
Weiss ET; Geronemus RG
Lasers Surg Med; 2010 Jul; 42(5):357-60. PubMed ID: 20583249
[TBL] [Abstract][Full Text] [Related]
3. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis.
Hofbauer GF; Marcollo-Pini A; Corsenca A; Kistler AD; French LE; Wüthrich RP; Serra AL
Br J Dermatol; 2008 Aug; 159(2):473-5. PubMed ID: 18547304
[TBL] [Abstract][Full Text] [Related]
4. Unilateral multiple facial angiofibromas: a mosaic form of tuberous sclerosis.
Silvestre JF; Bañuls J; Ramón R; Guijarro J; Botella R; Betlloch I
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):127-9. PubMed ID: 10863238
[TBL] [Abstract][Full Text] [Related]
5. Unilateral facial angiofibromas--a segmental form of tuberous sclerosis.
McGrae JD; Hashimoto K
Br J Dermatol; 1996 Apr; 134(4):727-30. PubMed ID: 8733380
[TBL] [Abstract][Full Text] [Related]
6. Dermacase. Tuberous sclerosis (Bourneville's disease).
Adams SP
Can Fam Physician; 1998 Jun; 44():1251, 1257. PubMed ID: 9640517
[No Abstract] [Full Text] [Related]
7. Treatment of the facial angiofibromas of tuberous sclerosis.
Verheyden CN
Plast Reconstr Surg; 1996 Oct; 98(5):777-83. PubMed ID: 8823013
[TBL] [Abstract][Full Text] [Related]
8. Oral manifestations leading to the diagnosis of familial tuberous sclerosis.
Martelli H; Lima LS; Bonan PR; Coletta RD
Indian J Dent Res; 2010; 21(1):138-40. PubMed ID: 20427926
[TBL] [Abstract][Full Text] [Related]
9. A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity.
Wataya-Kaneda M; Tanaka M; Nakamura A; Matsumoto S; Katayama I
Br J Dermatol; 2011 Oct; 165(4):912-6. PubMed ID: 21692771
[TBL] [Abstract][Full Text] [Related]
10. Unilateral angiofibromas. An oligosymptomatic and segmentary form of tuberous sclerosis.
Del Pozo J; Martínez W; Calvo R; Almagro M; Fonseca E
Eur J Dermatol; 2002; 12(3):262. PubMed ID: 11989480
[No Abstract] [Full Text] [Related]
11. Unilateral facial angiofibromas; a review of the literature.
Camprubí M; Balaguer A; Azon Masoliver A; Jiménez-Feijoo R; Escribano Subias J
Pediatr Dermatol; 2006; 23(3):303-5. PubMed ID: 16780491
[No Abstract] [Full Text] [Related]
12. Cryosurgery: an easy and cheap therapy for facial angiofibromas in tuberous sclerosis.
Schepis C; Siragusa M
Eur J Dermatol; 2010; 20(4):506-7. PubMed ID: 20403796
[No Abstract] [Full Text] [Related]
13. Segmental tuberous sclerosis presenting as unilateral facial angiofibromas.
Trauner MA; Ruben BS; Lynch PJ
J Am Acad Dermatol; 2003 Aug; 49(2 Suppl Case Reports):S164-6. PubMed ID: 12894111
[TBL] [Abstract][Full Text] [Related]
14. Oral health management implications in patients with tuberous sclerosis.
Cutando A; Gil JA; López J
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Oct; 90(4):430-5. PubMed ID: 11027378
[TBL] [Abstract][Full Text] [Related]
15. Targeted topical and combination laser surgery for the treatment of angiofibromas.
Bae-Harboe YS; Geronemus RG
Lasers Surg Med; 2013 Nov; 45(9):555-7. PubMed ID: 24136238
[TBL] [Abstract][Full Text] [Related]
16. A novel topical rapamycin cream for the treatment of facial angiofibromas in tuberous sclerosis complex.
Wheless JW; Almoazen H
J Child Neurol; 2013 Jul; 28(7):933-6. PubMed ID: 23680945
[TBL] [Abstract][Full Text] [Related]
17. Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis.
Haemel AK; O'Brian AL; Teng JM
Arch Dermatol; 2010 Jul; 146(7):715-8. PubMed ID: 20644030
[No Abstract] [Full Text] [Related]
18. Treatment of nodular facial angiofibromas in tuberous sclerosis, using ultrapulse carbon dioxide laser.
Biondo G; Greco S; Mavilia L; Mercuri SR
Clin Exp Dermatol; 2014 Aug; 39(6):738-40. PubMed ID: 24890518
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin therapy for renal, brain, and skin lesions in a tuberous sclerosis patient.
Micozkadioglu H; Koc Z; Ozelsancak R; Yildiz I
Ren Fail; 2010; 32(10):1233-6. PubMed ID: 20954988
[TBL] [Abstract][Full Text] [Related]
20. "Hot" KTP-laser treatment of facial angiofibromata.
Tope WD; Kageyama N
Lasers Surg Med; 2001; 29(1):78-81. PubMed ID: 11500867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
